DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03. – Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

The disclosure under Item 8.01 of this current report on Form 8-K is incorporated by reference.

Item 8.01. – Other Events.

On February 17, 2019, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) determined to extend the deadline for stockholders to nominate directors to the Board to the Company’s bylaws at the Company’s 2019 annual meeting of stockholders from February 22, 2019 to March 15, 2019. Any director nomination received by the Secretary of the Company prior to the close of business on March 15, 2019 and otherwise complying with the bylaws may be submitted to the stockholders at the Company’s 2019 annual meeting of stockholders. The date of the Company’s 2019 annual meeting of stockholders has not been set.

About DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA Inc., formerly DENTSPLY International Inc., designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products. The Company’s segments include Dental Consumables, Endodontic and Dental Laboratory Businesses; Healthcare, Orthodontic and Implant Businesses, and Select Developed and Emerging Markets Businesses. The Company’s principal product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Company distributes its products in over 120 countries. It offers brands, such as ANKYLOS, AQUASIL ULTRA, ARTICADENT, XIVE, ORAQIX, XYLOCAINE, ZHERMACK, IN-OVATION, LOFRIC, MAILLEFER, MIDWEST, NUPRO, ORIGO, OSSEOSPEED and PALODENT PLUS.